<DOC>
	<DOCNO>NCT01280149</DOCNO>
	<brief_summary>The purpose study determine whether neuropeptide , substance P , inject along allergen , ragweed , reduce allergic reactivity .</brief_summary>
	<brief_title>Reduction IgE Antibody Human Allergic Subjects</brief_title>
	<detailed_description>Allergic Rhinitis ( Hay fever ) affect many child adult risk factor development asthma . This study utilize neurotransmitter , substance P , small molecule present nerve ending , brain , skin , lungs gastrointestinal tract . Subjects receive substance P low dosage allergen , ragweed attempt reduce allergic reactivity .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<criteria>positive immediate type skin test ragweed grass pollen third ( standardize ) allergen ragweed grass pollen allergen positive volunteer available allergen injection cutaneous titration approximately 1 year start enrollment period volunteer pregnant lactate abnormal electrocardiogram subject 50 year age use beta adrenergic antagonists tricyclic antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>substance P</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>allergen immunotherapy</keyword>
</DOC>